• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳酸代谢:妇科癌症的致命弱点。

Lactic acid metabolism: gynecological cancer's Achilles' heel.

作者信息

Zhang Ting, Zhou Wenchao, Fan Tingyu, Yuan Yuwei, Tang Xing, Zhang Qunfeng, Zou Juan, Li Yukun

机构信息

The Second Affiliated Hospital, Department of Gynecology, Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, Hunan, China.

Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China.

出版信息

Discov Oncol. 2025 May 2;16(1):657. doi: 10.1007/s12672-025-02364-y.

DOI:10.1007/s12672-025-02364-y
PMID:40314877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12048388/
Abstract

Lactic acid is significantly expressed in many cancers, including gynecological cancer, and has become a key regulator of the proliferation, development, metastasis and invasion of these cancers. In clinical and experimental studies, the level of lactic acid in gynecological cancer is closely related to metastasis and invasion, tumor recurrence and poor prognosis. Lactic acid can regulate the internal metabolic pathway of gynecological cancer cells and drive the autonomous role of non-cancer cells in gynecological cancer. In addition to being used as a source of energy metabolism by gynecological cancer cells, lactic acid can also be transported from cancer cells to neighboring cancer cells, stroma and vascular endothelial cells (ECs) to further guide metabolic reprogramming. Lactic acid is also involved in promoting inflammation and angiogenesis in gynecologic tumors. Therefore, we reviewed the mechanisms and recent advances in the production and transport of lactic acid in gynecological cancer. These advances and evidence suggest that targeted lactic acid metabolism is a promising cancer treatment.

摘要

乳酸在包括妇科癌症在内的许多癌症中均有显著表达,并已成为这些癌症增殖、发展、转移和侵袭的关键调节因子。在临床和实验研究中,妇科癌症中的乳酸水平与转移和侵袭、肿瘤复发及预后不良密切相关。乳酸可调节妇科癌细胞的内部代谢途径,并驱动非癌细胞在妇科癌症中的自主作用。除了作为妇科癌细胞能量代谢的来源外,乳酸还可从癌细胞转运至邻近癌细胞、基质和血管内皮细胞,以进一步引导代谢重编程。乳酸还参与促进妇科肿瘤中的炎症和血管生成。因此,我们综述了妇科癌症中乳酸产生和转运的机制及最新进展。这些进展和证据表明,靶向乳酸代谢是一种很有前景的癌症治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/736bdbbf9e02/12672_2025_2364_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/9544cbb43e48/12672_2025_2364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/3a9754369e31/12672_2025_2364_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/dbf9fc856053/12672_2025_2364_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/18cc29f1b618/12672_2025_2364_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/736bdbbf9e02/12672_2025_2364_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/9544cbb43e48/12672_2025_2364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/3a9754369e31/12672_2025_2364_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/dbf9fc856053/12672_2025_2364_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/18cc29f1b618/12672_2025_2364_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/12048388/736bdbbf9e02/12672_2025_2364_Fig5_HTML.jpg

相似文献

1
Lactic acid metabolism: gynecological cancer's Achilles' heel.乳酸代谢:妇科癌症的致命弱点。
Discov Oncol. 2025 May 2;16(1):657. doi: 10.1007/s12672-025-02364-y.
2
Targeting lactate metabolism for cancer therapeutics.针对乳酸代谢的癌症治疗策略。
J Clin Invest. 2013 Sep;123(9):3685-92. doi: 10.1172/JCI69741. Epub 2013 Sep 3.
3
Tumor cell metabolism: cancer's Achilles' heel.肿瘤细胞代谢:癌症的致命弱点。
Cancer Cell. 2008 Jun;13(6):472-82. doi: 10.1016/j.ccr.2008.05.005.
4
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment.乳酸:肝癌微环境促进因子的叙述性综述
J Gastrointest Oncol. 2024 Jun 30;15(3):1282-1296. doi: 10.21037/jgo-24-368. Epub 2024 Jun 13.
5
Analysis of immune status and prognostic model incorporating lactic acid metabolism-associated genes.结合乳酸代谢相关基因的免疫状态分析及预后模型
Cancer Cell Int. 2024 Nov 14;24(1):378. doi: 10.1186/s12935-024-03555-3.
6
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel.替代性非同源末端连接:易出错的DNA修复——癌症的致命弱点
Cancers (Basel). 2021 Mar 19;13(6):1392. doi: 10.3390/cancers13061392.
7
The Achilles' Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials.胰腺癌的致命弱点:在临床试验中针对胰腺癌独特的免疫特征和代谢依赖性
J Pancreatol. 2020 Sep;3(3):121-131. doi: 10.1097/JP9.0000000000000052.
8
Mapping the expression and functional landscape of key enzymes in glucose metabolism within human gynecological tumors.绘制人类妇科肿瘤中葡萄糖代谢关键酶的表达图谱及功能全景。
Curr Probl Cancer. 2025 Feb;54:101155. doi: 10.1016/j.currproblcancer.2024.101155. Epub 2024 Nov 9.
9
Application of natural polysaccharides and their novel dosage forms in gynecological cancers: therapeutic implications from the diversity potential of natural compounds.天然多糖及其新型剂型在妇科癌症中的应用:天然化合物多样潜力的治疗意义
Front Pharmacol. 2023 Jun 13;14:1195104. doi: 10.3389/fphar.2023.1195104. eCollection 2023.
10
Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.纳米药物通过调节乳酸代谢来重塑免疫抑制性肿瘤微环境,以增强癌症免疫治疗效果。
Biomater Sci. 2022 Jul 12;10(14):3892-3900. doi: 10.1039/d2bm00650b.

本文引用的文献

1
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity.靶向程序性细胞死亡:细胞凋亡、坏死性凋亡、焦亡、铁死亡和铜死亡在抗癌免疫中的作用
J Transl Int Med. 2025 Mar 19;13(1):10-32. doi: 10.1515/jtim-2025-0004. eCollection 2025 Feb.
2
Intratumoral microbiota in orchestrating cancer immunotherapy response.肿瘤内微生物群在协调癌症免疫治疗反应中的作用。
J Transl Int Med. 2025 Jan 10;12(6):540-542. doi: 10.1515/jtim-2024-0038. eCollection 2024 Dec.
3
Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway.
肌动蛋白相关蛋白2/3复合体亚基1B通过调节AKT/PI3K/mTOR信号通路促进卵巢癌进展。
J Transl Int Med. 2024 Oct 1;12(4):406-423. doi: 10.2478/jtim-2024-0025. eCollection 2024 Sep.
4
Inhibition of heterogeneous nuclear ribonucleoproteins A1 and oxidative stress reduces glycolysis pyruvate kinase M2 in chronic thromboembolic pulmonary hypertension.抑制异质性核糖核蛋白A1和氧化应激可降低慢性血栓栓塞性肺动脉高压中的糖酵解丙酮酸激酶M2。
J Transl Int Med. 2023 Mar 19;12(4):437-451. doi: 10.2478/jtim-2022-0051. eCollection 2024 Sep.
5
A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma.癌症患者免疫相关不良事件的文献计量分析及肝细胞癌患者免疫相关不良事件的荟萃分析。
J Transl Int Med. 2024 Jul 27;12(3):225-243. doi: 10.2478/jtim-2024-0003. eCollection 2024 Jun.
6
Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.二硒键连接的二聚体前药纳米药物打破细胞内氧化还原平衡用于三阴性乳腺癌靶向治疗。
Eur J Pharm Biopharm. 2023 Dec;193:16-27. doi: 10.1016/j.ejpb.2023.10.014. Epub 2023 Oct 20.
7
In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER.基于计算机设计和细胞实验评估两种针对 Bcl-2 和 GPER 的双抗乳腺癌化合物。
Sci Rep. 2023 Oct 20;13(1):17933. doi: 10.1038/s41598-023-43860-x.
8
Hybrid computational modeling highlights reverse warburg effect in breast cancer-associated fibroblasts.混合计算模型突出了乳腺癌相关成纤维细胞中的反向沃伯格效应。
Comput Struct Biotechnol J. 2023 Aug 20;21:4196-4206. doi: 10.1016/j.csbj.2023.08.015. eCollection 2023.
9
Antitumor effect of trimetazidine in a model of solid Ehrlich carcinoma is mediated by inhibition of glycolytic pathway and AKT signaling.曲美他嗪在固体 Ehrlich 癌模型中的抗肿瘤作用是通过抑制糖酵解途径和 AKT 信号传导介导的。
Chem Biol Interact. 2023 Sep 25;383:110672. doi: 10.1016/j.cbi.2023.110672. Epub 2023 Aug 15.
10
Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.用 FX-11 和 AR-C155858 抑制剂靶向癌细胞中的单羧酸转运蛋白 MCT2 和乳酸脱氢酶 A LDHA。
Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6605-6617. doi: 10.26355/eurrev_202307_33131.